GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Global Wholehealth Partners Corp (OTCPK:GWHP) » Definitions » Debt-to-EBITDA

Global Wholehealth Partners (Global Wholehealth Partners) Debt-to-EBITDA : -1.04 (As of Jun. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Global Wholehealth Partners Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Global Wholehealth Partners's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.69 Mil. Global Wholehealth Partners's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.00 Mil. Global Wholehealth Partners's annualized EBITDA for the quarter that ended in Jun. 2022 was $-0.67 Mil. Global Wholehealth Partners's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2022 was -1.04.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Global Wholehealth Partners's Debt-to-EBITDA or its related term are showing as below:

GWHP's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.26
* Ranked among companies with meaningful Debt-to-EBITDA only.

Global Wholehealth Partners Debt-to-EBITDA Historical Data

The historical data trend for Global Wholehealth Partners's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Wholehealth Partners Debt-to-EBITDA Chart

Global Wholehealth Partners Annual Data
Trend Jun13 Jun14 Jun19 Jun20 Jun21 Jun22
Debt-to-EBITDA
Get a 7-Day Free Trial -1.57 - -0.05 -0.02 -0.17

Global Wholehealth Partners Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.04 -0.18 -0.35 -1.04

Competitive Comparison of Global Wholehealth Partners's Debt-to-EBITDA

For the Medical Devices subindustry, Global Wholehealth Partners's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Wholehealth Partners's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Global Wholehealth Partners's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Global Wholehealth Partners's Debt-to-EBITDA falls into.



Global Wholehealth Partners Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Global Wholehealth Partners's Debt-to-EBITDA for the fiscal year that ended in Jun. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.692 + 0) / -4.184
=-0.17

Global Wholehealth Partners's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.692 + 0) / -0.668
=-1.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2022) EBITDA data.


Global Wholehealth Partners  (OTCPK:GWHP) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Global Wholehealth Partners Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Global Wholehealth Partners's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Wholehealth Partners (Global Wholehealth Partners) Business Description

Traded in Other Exchanges
N/A
Address
1402 North El Camino Real, San Clemente, CA, USA, 92672
Global Wholehealth Partners Corp is a United States-based company that engages in the healthcare business. Its services include Colorectal Cancer Tests, Urinary Tract Infection Tests, Cholesterol Tests, Pregnancy Tests, and others.
Executives
Lai Kah Yin director, officer: CEO, CFO and Secretary JL. SUNTER KEMAYORAN NO. 168, JAKARTA ULTARA K8 14350

Global Wholehealth Partners (Global Wholehealth Partners) Headlines

From GuruFocus